PANoptosis

PANoptosis 是一种新型炎症性程序性细胞死亡通路,其整合焦亡、凋亡、坏死性凋亡三大通路的关键分子与表型,由 PANoptosome 复合体特异性调控。PANoptosis 存在广泛串扰,且无法通过单一通路阻断。PANoptosome 复合体可响应感染、应激等刺激,分传感器、衔接、效应蛋白三层,激活后同步触发膜破裂、内容物释放及炎症因子分泌。目前已明确 PANoptosome 复合体存在:ZBP1 (识别 Z-RNA)、AIM2 (识别 dsDNA)、RIPK1 (应答胞内菌感染) 及 NLRP12 (响应溶血事件) 四类亚型,且均依赖 IRF1 转录调控和受 ADAR1 等因子负向调节。PANoptosis 的四种亚型的核心组成分别为[1]:
1、ZBP1-PANoptosome 包含 ZBP1(传感器)、NLRP3、ASC、caspase-1/6/8、RIPK1/3。
2、AIM2-PANoptosome 包含 AIM2 (传感器)、Pyrin、ZBP1、ASC、caspase-1/8、RIPK1。
3、FADD RIPK1-PANoptosome 包含 RIPK1 (传感器)、RIPK3、NLRP3、ASC、caspase-1/8。
4、NLRP12-PANoptosome 包含 NLRP12 (传感器)、ASC、caspase-8、RIPK3。
PANoptosis 在疾病中呈现显著的双刃剑效应:在抗感染、抗肿瘤中发挥宿主保护作用,在过度炎症、细胞因子风暴、器官损伤中则介导病理损伤;其参与的疾病覆盖感染、肿瘤、炎症性器官损伤、自身免疫病等多个领域[2]。
PANoptosis 研究聚焦了前沿技术与核心课题,不仅依托膨胀显微镜实现单细胞 PANoptosome 成像、CRISPR 筛选鉴定调控因子、基因编辑模型与类器官模拟疾病环境、多组学解析调控网络、结构生物学指导高通量药物筛选,在解析新型传感器与细胞死亡串扰机制、开发疾病特异性精准调控策略、靶向药物 (肿瘤/感染) 开发与临床转化、肿瘤免疫联合治疗方案、临床生物标志物挖掘及细胞类型特异性调控机制,推动精准诊疗创新等方面有长足的研究热度[1][2]。

PANoptosis is a novel pathway of inflammatory programmed cell death (PCD) that integrates key molecular components and phenotypic features from three major pathways-pyroptosis, apoptosis, and necroptosis-and is specifically regulated by the PANoptosome complex. PANoptosis involves extensive crosstalk and cannot be blocked by inhibiting any single pathway alone. PANoptosis exerts host-protective effects in anti-infective and anti-tumor contexts, while mediating pathological damage in cases of excessive inflammation, cytokine storms, and organ injury.
The PANoptosome complex responds to stimuli such as infection and cellular stress; it is organized into three functional layers-sensor, adaptor, and effector proteins-and, upon activation, simultaneously triggers membrane rupture, the release of cellular contents, and the secretion of inflammatory cytokines. Currently, four distinct subtypes of the PANoptosome complex have been identified: ZBP1 (which recognizes Z-RNA), AIM2 (which recognizes dsDNA), RIPK1 (which responds to intracellular bacterial infections), and NLRP12 (which responds to hemolytic events). All four subtypes are dependent on transcriptional regulation by IRF1 and are negatively regulated by factors such as ADAR1. The core components of the four PANoptosis subtypes are as follows[1]:
1. ZBP1-PANoptosome contains: ZBP1 (sensor), NLRP3, ASC, caspase-1/6/8, RIPK1/3.
2. AIM2-PANoptosome contains: AIM2 (sensor), Pyrin, ZBP1, ASC, caspase-1/8, RIPK1.
3. FADD-RIPK1-PANoptosome contains: RIPK1 (sensor), RIPK3, NLRP3, ASC, and Caspase-1/8.
4. NLRP12-PANoptosome contains: NLRP12 (sensor), ASC, Caspase-8, and RIPK3.

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MNS
NSC 170724; 5-(2-Nitrovinyl)benzodioxole

MNS (NSC 170724) 是一种 β-硝基苯乙烯衍生物,作为口服活性的酪氨酸激酶抑制剂、广谱抗血小板活性分子和泛凋亡 (PANoptosis) 抑制剂,可抑制 Src、Syk 和 FAK(IC50 分别为 27.3、2.8 和 97.6 μM)以及 NLRP3 炎症小体和 β1 整合素,并能完全抑制 U46619、ADP、花生四烯酸、胶原和凝血酶诱导的血小板聚集(IC50 值分别为 2.1、4.1、5.8、7.0 和 12.7 μM),同时对多种细胞具有细胞毒性。

1485-00-3
Inhibitor
MNS
Melatonin
褪黑素; N-Acetyl-5-methoxytryptamine

Melatonin 是一种由松果体分泌的激素,可激活褪黑激素受体并抑制泛凋亡 (PANoptosis),在睡眠中起作用且具有重要的抗氧化和抗炎特性,同时作为一种新型的选择性 ATF-6 抑制剂可通过 COX-2 下调诱导人肝癌细胞凋亡,并通过内质网应激减弱 palmitic acid-induced (MS-A29753) 诱导的小鼠颗粒细胞凋亡 (apoptosis)。

73-31-4
Inhibitor
99.93%
褪黑素;褪黑激素;美拉酮宁;抑黑素;松果腺素;松果体素

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础